evidence table
Probiotics Skin Randomized Trial Evidence Table
Structured evidence table for Probiotics Skin Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Probiotics Skin Randomized Trial | objective Theof this paper is to analyze the available scientific evidence on the cutaneous microbiome and its relationship with skin health. | 4 | Taléns‐Visconti Raquel (2026) | Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions |
| Probiotics Skin Randomized Trial | acnes 14 15 16 2 15 12 12 2 3 3 17 18 19 13 15 16 The skin microbiome shifts notably throughout life, from the low diversity observed in newborns, to the emergence of lipophilic species with puberty, and typically an increase in overall alpha diversity in older adults due to reduced dominance of protective commensals such asand, coupled with higher representation of environmental/transient species [,]. | 4 | Taléns‐Visconti Raquel (2026) | Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions |
| Probiotics Skin Randomized Trial | A study found that women exhibit higher alpha diversity than men, indicating a richer and more balanced microbiota []. | 4 | Taléns‐Visconti Raquel (2026) | Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions |
| Probiotics Skin Randomized Trial | 1 Human skin, owing to its large surface area, plays a key role as the primary point of direct contact with the environment. | 4 | Taléns‐Visconti Raquel (2026) | Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions |
| Probiotics Skin Randomized Trial | This narrative review evaluates current evidence regarding the role of biotics in rosacea. | 4 | Avendaño-Pérez AL (2026) | The Role of Biotics in Rosacea: A Narrative Review. |
| Probiotics Skin Randomized Trial | Evidence supporting the use of prebiotics, postbiotics, and synbiotics in rosacea remains limited and, in many cases, extrapolated from related inflammatory conditions or preclinical models. | 4 | Avendaño-Pérez AL (2026) | The Role of Biotics in Rosacea: A Narrative Review. |
| Probiotics Skin Randomized Trial | Although microbiota modulation represents a promising therapeutic avenue, current evidence is insufficient to establish standardized clinical recommendations. | 4 | Avendaño-Pérez AL (2026) | The Role of Biotics in Rosacea: A Narrative Review. |
| Probiotics Skin Randomized Trial | Rosacea is a chronic inflammatory dermatosis affecting the central face of adults, characterized by persistent erythema, flushing, papules, pustules, telangiectasias, and, in some cases, phymatous changes. | 4 | Avendaño-Pérez AL (2026) | The Role of Biotics in Rosacea: A Narrative Review. |
Source documents